Growth Stocks
Although growth stock picks can be highly volatile, they can make good long-term investments. They may be well-known stars or quiet gems, but they do share one common attribute—they are growing at a higher-than-average rate within their industry, or within the market as a whole, and could keep growing for years or decades.
And keep in mind that we focus on growth stocks, which have a good long-term history and favourable prospects. We downplay momentum stocks that tend to attract many investors simply because they are moving faster than the market averages, but are liable to fall sharply when their momentum fades.
There’s room for growth stock investing in your portfolio, but make sure you follow our TSI Network three-part Successful Investor strategy for your overall portfolio:
- Invest mainly in well-established companies;
- Spread your money out across most if not all of the five main economic sectors (Manufacturing & Industry; Resources & Commodities; Consumer; Finance; Utilities);
- Downplay or avoid stocks in the broker/media limelight.
Make better stock picks when you read this FREE Special Report, Canadian Growth Stocks: WestJet Stock, RioCan Stock and More.
Read More
Close
Growth Stocks Library Archives
You Can See Our Current Power Recommendations For March 2026 Here.
Understanding our recommendations: Power Buy—These stocks are our top choices for new buying now. We feel each currently offers the best combination of fundamentals (earnings, sales, cash flow and so on) plus external factors (industry trends and the current share price) to give it a chance of above-average gains. Buy—high-quality stocks with strong growth prospects. However, they are likely to grow at a slower rate than our Power Buys. Sell—these are stocks that no longer inspire our confidence. As Power Growth Investor focuses on maximizing profits for aggressive investors, we prefer to sell poorly performing stocks instead of holding them and waiting for a rebound.
Understanding our recommendations: Power Buy—These stocks are our top choices for new buying now. We feel each currently offers the best combination of fundamentals (earnings, sales, cash flow and so on) plus external factors (industry trends and the current share price) to give it a chance of above-average gains. Buy—high-quality stocks with strong growth prospects. However, they are likely to grow at a slower rate than our Power Buys. Sell—these are stocks that no longer inspire our confidence. As Power Growth Investor focuses on maximizing profits for aggressive investors, we prefer to sell poorly performing stocks instead of holding them and waiting for a rebound.
Current economic uncertainty and lower consumer confidence have slowed the rise of both Wyndham, and Travel + Leisure. But we believe each company still have exceptional prospects. What’s more, each is a market leader, which cuts your investment risk. WYNDHAM HOTELS & RESORTS, $80.24, is a buy. The company (New York symbol WH; TSINetwork Rating: Extra Risk) (www.wyndhamhotels.com; Shares o/s: 75.6 million; Market cap: $6.1 billion; Dividend yield: 2.0%) is the world’s largest hotel franchiser, with 868,900 rooms spread across 8,300 hotels, with 25 brands in 100 countries.
Long-time readers know that we aim to keep you informed of important news about the stocks we cover. That means highlighting developments and plans that promise to bolster investor gains. Here are two buys that stand out this month: AMAZON.COM INC., $204.79, remains a buy. The company (Nasdaq symbol AMZN; TSINetwork Rating: Average) (www.amazon.com; Shares outstanding: 10.7 billion; Market cap: $2.2 trillion; No dividends paid) now says it will cut around 16,000 corporate employees, the latest step in the technology giant’s efforts to slim down its workforce. The first round of cuts, in October, led to around 14,000 white-collar employees being let go.
CORTEVA INC., $76.59, is a buy. The company (New York symbol CTVA; TSINetwork Rating: Extra Risk) (www.corteva.com; Shares o/s: 672.2 million; Market cap: $51.5 billion; Dividend yield: 1.0%) and BP plc (symbol BP on New York) have announced the launch of Etlas, their new joint venture focused on producing oil from canola, mustard and sunflower crops for use in biofuels.
We see bright outlooks for Calian and ATS given their high-demand services and the resulting prospects for growth. Both are buys.
CALIAN GROUP, $76.30, is a buy. The stock (Toronto symbol CGY; TSINetwork Rating: Extra Risk) (calian.com; Shares outstanding: 11.4 million; Market cap: $869.8 million; Dividend yield: 1.5%) lets investors tap the Ottawa-based company’s four main operating segments:
CALIAN GROUP, $76.30, is a buy. The stock (Toronto symbol CGY; TSINetwork Rating: Extra Risk) (calian.com; Shares outstanding: 11.4 million; Market cap: $869.8 million; Dividend yield: 1.5%) lets investors tap the Ottawa-based company’s four main operating segments:
You should remain wary of stocks that attract broker/media attention because of high-profile products or services, and their business models. Here’s a closer look at one stock with risks that prospective investors should take into consideration:
ALCON, $82.29, remains a buy. The firm (New York symbol ALC; TSINetwork Rating: Average) (www.alcon.com; Shares outstanding: 491.2 million; Market cap: $40.4 billion; Dividend yield 0.4%) has just completed the massive share repurchase program that it commenced on April 1, 2025.
ResMed’s sales and profits got a boost during the pandemic with a sharp rise in demand for its ventilators and other respiration devices.
Even as the pandemic eased, the gains continued as the company introduced more products and expanded its software offerings. Today, ResMed’s outlook remains attractive—and not solely because of its CPAP machines.
We think this Power Buy is poised to move even higher for you.
Even as the pandemic eased, the gains continued as the company introduced more products and expanded its software offerings. Today, ResMed’s outlook remains attractive—and not solely because of its CPAP machines.
We think this Power Buy is poised to move even higher for you.
Alimentation Couche-Tard has made major acquisitions over the last decade and, in fact, has just completed one more. While growth by acquisition adds risk, this retailer has a track record of successfully integrating the businesses it buys. Moreover, it’s well-positioned to keep prospering in both its core markets and its new ones. Couche-Tard is a Power Buy.
ALIMENTATION COUCHE-TARD, $83.47, is a buy. This retailer (Toronto symbol ATD; TSINetwork Rating: Average) (couchetard.com; Shares o/s: 925.8 million; Market cap: $77.3 billion; Yield: 1.0%) operates 14,637 convenience stores, mostly in North America and Europe.
ALIMENTATION COUCHE-TARD, $83.47, is a buy. This retailer (Toronto symbol ATD; TSINetwork Rating: Average) (couchetard.com; Shares o/s: 925.8 million; Market cap: $77.3 billion; Yield: 1.0%) operates 14,637 convenience stores, mostly in North America and Europe.
Metro’s shares are down 13% since reaching a new all-time high of $109 in May 2025. The decline is partly due to problems at a refrigerated warehouse near Toronto. Even so, the company stands to benefit from a multi-year plan to automate and modernize its distribution network; that should spur earnings and let it keep raising your dividend.
METRO INC. $95 is a buy. The company (Toronto symbol MRU; Aggressive Growth Portfolio, Consumer sector; Shares outstanding: 213.2 million; Market cap: $20.3 billion; Price-to-sales ratio: 0.9; Dividend yield: 1.7%; TSINetwork Rating: Average; www.metro.ca) operates 1,007 food stores in Quebec and Ontario under several banners, including Metro, Food Basics and Super C. It also has 637 drugstores in Quebec, Ontario and New Brunswick under the Jean Coutu, Brunet, Metro Pharmacy and Food Basics Pharmacy banners.
METRO INC. $95 is a buy. The company (Toronto symbol MRU; Aggressive Growth Portfolio, Consumer sector; Shares outstanding: 213.2 million; Market cap: $20.3 billion; Price-to-sales ratio: 0.9; Dividend yield: 1.7%; TSINetwork Rating: Average; www.metro.ca) operates 1,007 food stores in Quebec and Ontario under several banners, including Metro, Food Basics and Super C. It also has 637 drugstores in Quebec, Ontario and New Brunswick under the Jean Coutu, Brunet, Metro Pharmacy and Food Basics Pharmacy banners.